XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Nov. 03, 2024
Oct. 29, 2023
OPERATING ACTIVITIES    
Net income $ 441.3 $ 391.8
Adjustments to reconcile to net cash provided by operating activities:    
Depreciation and amortization 211.6 223.0
Equity in net income of unconsolidated affiliates (34.7) (34.8)
Deferred taxes (11.9) (28.8)
Stock-based compensation expense 39.1 39.5
Other gain (19.5) 0.0
Changes in operating assets and liabilities:    
Trade receivables, net (186.6) (148.8)
Other receivables (1.2) 3.7
Inventories, net (188.2) 231.1
Accounts payable, accrued expenses and deferred revenue (0.9) (358.2)
Prepaid expenses 16.2 (3.5)
Other, net (10.8) (3.3)
Net cash provided by operating activities 254.4 311.7 Close
INVESTING ACTIVITIES    
Purchases of property, plant and equipment (115.4) (163.3)
Proceeds from sale of Warner's, Olga and True&Co. women's intimates businesses 5.0 0.0
Purchases of investments held in rabbi trust (4.1) (3.3)
Proceeds from investments held in rabbi trust 0.9 1.3
Proceeds from cross-currency swap contracts (net investment hedges) 3.5 0.0
Proceeds from sale of warehouse and distribution center 9.5 0.0
Net cash used by investing activities (100.6) (165.3) Close
FINANCING ACTIVITIES    
Net proceeds from (payments on) from short-term borrowings 0.0 (24.7)
Repayment of 2022 facilities (9.0) (8.9)
Net proceeds from settlement of awards under stock plans 7.3 0.0
Proceeds from 4 1/8% senior notes, net of related fees 553.1 0.0
Redemption of 3 5/8% senior notes (561.7) 0.0
Cash dividends (6.4) (7.1)
Acquisition of treasury shares (280.2) (286.7)
Payments of finance lease liabilities (3.1) (3.4)
Net cash used by financing activities (300.0) (330.8) Close
Effect of exchange rate on cash and cash equivalents (1.8) (8.7) Close
Decrease in cash and cash equivalents (148.0) (193.1) Close
Cash and cash equivalents at beginning of period 707.6 550.7
Cash and cash equivalents at end of period $ 559.6 $ 357.6